Sensitive skin
Conditions
Interventions
Treatment group:At day 0, day 30 and day 60, each subject was given 4ml of placental polypeptide injection
Control group:None
Sponsors
Peking Union Medical College Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) Male or female, 18 years old or above (including 18 years old); 2) In patients with moderate to severe sensitive skin, lactic acid stimulation test was positive, total score: =3 points; 3) Those who are willing to give up facial cosmetic treatments that may interfere with the study results during the study period; 4) Those who voluntarily sign the informed consent. Note: All of the above are "Yes" to be selected.
Exclusion criteria
Exclusion criteria: 1) Female subjects who are pregnant, breastfeeding or not using contraception; 2) known allergy to any part of the study product; 3) Patients with infectious lesions or inflammatory lesions on the facial skin that require treatment; 4) Have a history of hypertrophic scar or keloid; 5) Conditions considered unsuitable for inclusion in this study by other researchers. Note: All the above items are "No" to be selected.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin hemoglobin content; | — |
Secondary
| Measure | Time frame |
|---|---|
| Erythema skin area;Skin roughness improvement;Skin wrinkle score;Dermal thickness;GAIS fractionation; | — |
Countries
China
Contacts
Public ContactQiuning Sun
Peking Union Medical College Hospital
Outcome results
None listed